Home
Faculty Directory
Tiffany Lu, M.D., M.S.

Tiffany Lu, M.D., M.S.

Associate Professor, Department of Medicine (General Internal Medicine)

Area of Research: Opioid use disorder, buprenorphine treatment, addiction medicine education and workforce development

Contact Information

718.920.4687718.405.8050tlu@montefiore.org

Montefiore Medical Center
3330 Kossuth Avenue
Bronx, NY 10467

Research Profiles

Is this your profile? Edit profile

Professional Interests

Tiffany Lu, MD, MS is an Associate Professor of Medicine at Montefiore Health Systems and Albert Einstein College of Medicine in Bronx, New York. She is the Medical Director of Montefiore's Buprenorphine Treatment Network, where she leads an interdisciplinary team of primary care clinicians and treatment coordinators to deliver opioid use disorder treatment and overdose prevention services across 7 community health centers. Dr. Lu is also the principal investigator of a SAMHSA grant award to expand addiction medicine education at Montefiore-Einstein, which includes a new, structured clinical rotation in addiction medicine for medical residents. Additionally, she founded Montefiore's Addiction Medicine "Bridge" Clinic to provide interdisciplinary care for patients who are new to medications for addiction treatment. Dr Lu's research focus is on innovations and outcomes in primary care-based addiction treatment, particularly in low-income and racial minority communities disproportionally affected by overdose deaths.

Prior to joining Montefiore-Einstein, Dr. Lu graduated from University of California in San Francisco (UCSF) School of Medicine and completed her residency training in the Primary Care Internal Medicine Residency Program at Massachusetts General Hospital. She holds a Masters of Science in Clinical Research Methods from Albert Einstein College of Medicine. She is board certified in Internal Medicine and Addiction Medicine.

Selected Publications

Original Research

Singh-Tan S, Torres-Lockhart K, Jakubowski A, Lu T, Starrels J, De Lima P, Arnsten J, Nahvi S, Southern W. Addiction consult service and inpatient outcomes among patients with alcohol use disorder. J Gen Intern Med. 2023 Apr 26:1–8. doi: 10.1007/s11606-023-08202-7. PMID: 37100986; PMCID: PMC10132408.

Jakubowski A, Singh-Tan S, Torres-Lockhart K, Nahvi S, Stein M, Lu T. Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation. Addict Sci Clin Pract. 2023 May 18;18(1):31. doi: 10.1186/s13722-023-00386-x. PMID: 37198707; PMCID: PMC10193697.

Khalid L, Cunningham CO, Deng Y, Masyukova M,...Lu T. Cascade of care for office-based buprenorphine treatment in Bronx community clinics. J Subst Abuse Treat. 2022 Aug;139:108778. doi: 10.1016/j.jsat.2022.108778. Epub 2022 Apr 9. PMID: 35428524.

Cunningham CO, Khalid L, Deng Y,…Lu T. A comparison of office-based buprenorphine treatment outcomes in Bronx community clinics before versus during the COVID-19 pandemic. J Subst Abuse Treat. 2022 Apr;135:108631. doi: 10.1016/j.jsat.2021.108641. Epub 2021 Oct 27. PMID: 34863608

Jakubowski A, Lu T, Direnno F, Jadow B, Giovanniello A, Cunningham CO, Fox AD. Same-day vs. delayed buprenorphine prescribing and patient retention in an office-based buprenorphine treatment program. J Subst Abuse Treat. 2020 Dec;119:108140. doi: 10.1016/j.jsat.2020.108140. PMID: 33138925.

Clinical Guidelines, Reviews, and Chapters

Lu T. Treatment of Opioid Use Disorder. 2023 Sept 12. In: New York State Department of Health AIDS Institute – Clinical Guidelines Program. Available from: https://www.hivguidelines.org/opioid-use-disorder

Torres-Lockhart KE, Lu T, Weimer MB, Stein MR, and Cunningham CO. Clinical management of opioid withdrawal. Addiction. 2022 Sept; 117(9):2540-2550. doi: 10.1111/add.15818. Epub 2022 Feb 22. PMID: 35112746

Lu T, Stein M, and Fox AD. Primary care management of adults with opioid use disorder. In: UpToDate, Post TW (Ed). UpToDate, Waltham, MA; 2021.

Slawek D, Lu T, Hayes B, and Fox AD. Caring for patients with opioid use disorder – what clinicians should know about comorbid medical conditions. Psych Res Clin Pract 2019;1:16-26. doi: 10.1176/appi.prcp.20180005

In the News

Q&A: How Can PCPs Properly Manage Patients With Opioid Use Disorder?

Healio - January 26, 2022

Tiffany Lu, M.D., M.S., describes her grant that will fund the expansion of addiction medicine and training programs for medical students and residents at Einstein and Montefiore. The curriculum will focus on the diagnosis and care for people with opioid use disorder, including guidance about medications for addiction treatment, particularly buprenorphine. Dr. Lu is assistant professor of medicine at Einstein and director of the Montefiore Buprenorphine Treatment Network.

Quick Links

Faculty Profile

Tiffany Lu, M.D., M.S.

Contact Information

Professional Interests

Selected Publications

Related News

Feature

From Students to Physicians: New Course Prepares Students for Hospital Roles

News Release

Albert Einstein College of Medicine and Montefiore Health System Receive Federal Grant to Expand Addiction Medicine Education and Training

In the News

About Einstein

Administration

Alumni

Careers

Centers (Research)

Contact Us

Departments

Diversity

Donors

Education

Einstein Senate

Faculty Directory

Health

INTRANET

Library

Luminis Portal

Newsroom

Policies

Research

Video

Visitors

Webmail